These results are particularly relevant in view of recent studies demonstrating that, besides its antioxidant function, HMOX1 is involved in mitochondrial biogenesis in CLL and could represent a potential therapeutic target [23]. Here, HMOX1 is linked to B-cell chronic lymphocytic leukemia.